trending Market Intelligence /marketintelligence/en/news-insights/trending/-DQrv7oFYRfPQAQ-by51rw2 content esgSubNav
In This List

Rhythm Biosciences appoints COO

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Rhythm Biosciences appoints COO

Rhythm Biosciences Ltd. appointed Glenn Gilbert as COO.

Most recently, Gilbert served as head of sales and marketing, with oversight of global product commercialization, at pharmaceutical and device maker Medical Developments International Ltd.

Gilbert has previously held leadership roles at CSL Ltd.'s biotherapeutics arm, now known as Seqirus.

Australia-based Rhythm Biosciences develops and commercializes medical diagnostics technology.